期刊文献+

冬凌草甲素抗Ph染色体阳性急性淋巴细胞白血病效应的实验研究 被引量:10

Anti-leukemia effect of oridonin on Ph+ acute lymphoblastic leukemia cell
原文传递
导出
摘要 目的探讨冬凌草甲素对Ph染色体阳性(Pb+)急性淋巴细胞白血病(ALL)的抗白血病效应及其机制。方法以Ph+ALL细胞株SUP—B15为研究对象,应用改良MTT法测定冬凌草甲素对SUP—B15细胞增殖的影响,计算72h的半数抑制浓度(IC50);光学显微镜下观察冬凌草甲素处理后SUP—B15细胞的形态学变化;用流式细胞术检测药物作用前后SUP—B15细胞的凋亡率;以K562细胞为对照,应用Westernblot法比较药物作用前后SUP—B15细胞Akt/mTOR、Raf/MEK/ERK、STAT5信号转导通路活化水平,以及凋亡调节蛋白Bcl-2和Bax的变化。结果①冬凌草甲素呈浓度及时间依赖地抑制SUP—B15细胞增殖,作用72h的IC50值为(7.08±1.21)μmol/L;②冬凌草甲素处理24h后光学显微镜下SUP—B15细胞边界不清晰,部分细胞崩解;③0、5、10μmol/L冬凌草甲素作用24h后,SUP—B15细胞凋亡百分率分别为(6.67±0.83)%、(18.30±1.79)%、(37.63±7.12)%;④冬凌草甲素明显抑制SUP-B15细胞ABL酪氨酸激酶及其下游Akt/mTOR、Raf/MEK/ERK、STAT5多条信号转导通路的活化;下调SUP.B15细胞抗凋亡蛋白Bcl-2的表达,上调促凋亡蛋白Bax的表达。结论冬凌草甲素通过抑制ABL酪氨酸激酶及其下游Akt/mTOR、Raf/MEK/ERK、STAT5信号转导,以及上调促凋亡蛋白Bax、下调抗凋亡蛋白Bcl-2而发挥抗Ph+ALL作用。 Objective To investigate the anti-leukemia effect of oridonin on Ph+ acute lymphoblastic leukemia(ALL) cell line SUP-B15. Methods Human Ph+ ALL cell line was cultured in vitro. The 50% inhibition concentration (1C50) of oridonin against SUP-B15 cell line was examined using modified MTr assay. The cellular morphologic changes were observed using a light microscope. The percent of apoptosis of SUP-B15 cell line after drug treatment was evaluated by flow cytometric analysis. The active levels of ABL ki- nase and its downstream Akt/mTOR, Raf/MEK/ERK, STATS signaling pathways and the expression levels of Bcl-2 and BAX were examined by Western blot. Results Oridonin inhibited the growth of SUP-B15 cell line in both time- and dose-dependent manner with the ICs0 of oridonin as (7.08 ±1.21 )μmol/L after 72 h treat- ment. The cellular membrane of SUP-B15 cell line treated with oridonin became unsharp, some of them disintegrated. Oridonin induced apoptosis in SUP-B15 cell line with the apoptosis rates following 0, 5, 10 μmol/L oridonin treatment for 24 h were (6.67 ± 0.83 ) %, ( 18.30 ± 1.79 ) % and (37.63± 7.12 ) %, respectively. Oridonin inhibited activation of ABL kinase and its downstream Akt/mTOR, Raf/MEK/ERK and STATS signaling pathways,which were constitutively activated in SUP-B15 cell line, down-regulated the level of anti- apoptotic protein Bcl-2 and up-regulated the expression of pro-apoptotic protein Bax. Conclusion Oridonin exerted anti-leukemia effect in Ph+ ALL cell line SUP-B15 by inhibiting the activation of ABL kinase and its downstream Akt/mTOR, Raf/MEK/ERK and STATS signaling pathways, down-regulating the expression of Bcl-2 and up-regulating the expression of BAX.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2012年第6期439-443,共5页 Chinese Journal of Hematology
基金 国家自然科学基金(30770912) 四川省科技厅社会公益项目(2008SZ0017) 教育部回国留学人员启动基金(20071108-18-4)
关键词 白血病 淋巴细胞 急性 费城染色体 细胞增殖 细胞凋亡 冬凌草素 细胞内信号肽和蛋白质类 Leukemia,lymphocytic, acute Philadelphia chromosome Cell proliferation Apoptosis Rubescensine Intracellular signaling peptides and proteins
  • 相关文献

参考文献14

  • 1Kurzrock R, Kantarjian HM, Druker B J, et al. Philadelphia chro- mosome-positive leukemias: from basic mechanisms to molecular therapeutics. Ann Intern Med, 2003, 138:819-830.
  • 2Laurent E, Talpaz M, Kantarjian H, el al. The BCR gene and philadelphia chromosome-positive leukemogenesis. Cancer Res, 2001,61:2343-2355.
  • 3Nieborowska-Skorska M, Wasik MA, Slupianek A, et al. Signal transducer and activator of transcription (STAT) 5 activation by BCR/ABL is dependent on intact Src homology (SH) 3 and SH2 domains of BCR/ABL and is required for leukemogenesis. J Exp Med, !999,189 : !229-1 242,.
  • 4Skorski T, Bellacosa A, Nieborowska-Skorska M, et al. Transfor- mation of hematopoietic cells by BCR/ABL requires activation of a PI-3 k/Akt-dependent pathway. EMBO J, 1997,16:6151-6161.
  • 5lkezoe T, Chen SS, Tong X J, el al. Oridonin induces growth inhi- bition and apoptosis of a variety of human cancer cells. Int J On- col, 2003,23 : 1187-1193.
  • 6杨曦,龚玉萍,杨雷,周睿卿,邢宏运,郑波慧.雷帕霉素单药及联合硼替佐米、柔红霉素对白血病细胞株抗肿瘤效应的研究[J].中华血液学杂志,2010,31(3):201-203. 被引量:7
  • 7Hsieh TC, Wijeratne EK, Liang JY, et al. Differential control of growth, cell cycle progression, and expression of NF-kappaB in human breast cancer ceils MCF-7, MCF-10A,and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the chinese herb Rabdosia rubescens. Biochem Biophys Res Commun, 2005,337 : 224 -231.
  • 8Cheng Y, Qiu F, Ye YC, et al. Oridonin induces G2/M arrest and apoptosis via activating ERK-p53 apoptotie pathway and inhibiting PTK-Ras-Raf-JNK survival pathway in murine brosarcoma L929 cells. Arch Biochem Biophys,2009,490:70-75.
  • 9Li D, Wu LJ, Tashiro S, et al. Oridonin inhibited the tyrosine ki- nase activity and induced apoptosis in human epidermoid carcino- ma A431 cells. Biol Pharm Bu11,2007,30:254-260.
  • 10Jin S, Shen JN, Wang J, et al. Oridonin induced apoptosis through Akt and MAPKs signaling pathways in human osteosar- coma cells. Cancer Biol Ther,2007,6 : 261-268.

二级参考文献8

  • 1周建军,乐秀芳,韩家娴,杨蔚怡.评价抗癌物质活性的改良MTT方法[J].中国医药工业杂志,1993,24(10):455-457. 被引量:108
  • 2郑杰.mTOR信号途径与肿瘤[J].生命科学,2006,18(3):261-265. 被引量:20
  • 3Witzig TE,Kaufmann SH.Inhibition of the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway in hematologic malignancies.Curr Treat Options Oncol.2006.7:285-294.
  • 4Tcachey DT,Gmpp SA,Brown VI.Mammalian target of rapamycin inhibitors and their potential role in therapy in leukaemia and other haematological malignancies.Br J Haematol,2009,145:569-580.
  • 5Wang DG,Wang ZP,Tian BQ,et al.Two hour expogtlreto sodium butyrate sensitizes bladder cancer to anticancer drugs.Inter J Urol,2008,15:435-441.
  • 6Steelman LS,Abrams SL,Bertrand FE,et al.Contributions of the Raf/MEK/ERK,PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia.Leukemia,2008,22:686-707.
  • 7Shaw RJ,Cantley LC.Ras,PI(3)K and mTOR signaling controls tumour cell growth.Nature,2006,441:424-430.
  • 8Hirase C,Maeda Y,Takai S,et al.Hypersensitivity of Ph-positive lymphoid cell lines to rapamyein:possible clinical application of mTOR inhibitor.Leuk Res,2009,33:450-459.

共引文献6

同被引文献135

引证文献10

二级引证文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部